Guillermo M. S.
- Country
- Spain
- Department
- 172416: Hematología
Research Overview
- A Phase 1/2 Study of Enzomenib (DSP 5336) in Adults with Relapsed or Refractory Acute Leukemia, Including MLL-Rearranged or NPM1-Mutated Subtypes
- Phase 3 Randomized, Double-blind, Placebo-controlled Study of Tamibarotene and Azacitidine in RARA-positive Higher-risk Myelodysplastic Syndrome
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Bleximenib, Venetoclax, and Azacitidine in Acute Myeloid Leukemia with KMT2A Rearrangements or NPM1 Mutations
Data & Insights
Has run more than one trial at 77 of 221 partner sites.
Specializations
Hematologic Malignancies
This investigator specializes in treating complex blood disorders, with particular emphasis on myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Their work encompasses the investigation of novel therapeutic approaches for patients with these challenging conditions.
- Higher-risk MDS treatment
- RARA-positive disease management
- AML with genetic alterations
The investigator's expertise extends to treating patients with specific genetic markers, including KMT2A/MLL, NPM1, and NUP98 gene alterations.
Targeted Therapies
Their research focus includes the development and implementation of targeted therapeutic approaches for hematologic conditions. The investigator works with novel treatment combinations including tamibarotene and azacitidine for specific patient populations.
- Combination therapy approaches
- Molecular targeting strategies
- Personalized treatment protocols
The investigator's work involves identifying and treating patients based on specific molecular and genetic markers.
Adult Hematology
The investigator concentrates on treating adult patients with newly diagnosed hematologic conditions. Their expertise includes both standard and intensive therapeutic approaches for various blood disorders.
- Treatment of newly diagnosed patients
- Intensive chemotherapy protocols
- Response rate assessment
Their work encompasses comprehensive evaluation of treatment efficacy in adult patients with blood disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.